Common use of JSC Responsibilities Clause in Contracts

JSC Responsibilities. Responsibilities of the JSC shall be the following: (i) Discussing and reviewing the development and regulatory strategies and activities for the Licensed Products in and outside the Territory and, to the extent reasonably possible, coordinating strategies in and outside the Territory; (ii) Discussing and reviewing the commercialization strategies and activities of the Licensed Products in and outside the Territory and, to the extent reasonably possible, coordinating strategies in and outside the Territory; (iii) Discussing and reviewing the matters relating to supply that are not specifically addressed within the Supply Agreement of the Licensed Products by BIAL to NBIX for use hereunder; (iv) Discussing, reviewing and approving the Development and Regulatory Plan and amendments thereto prior to adoption or implementation thereof; (v) Discussing, reviewing and approving the Annual Commercialization Plan, and updates or amendments thereto prior to adoption or implementation thereof; (vi) Reporting on the status of ongoing Development Studies and other development activities with respect to Licensed Products in the Field in and, to the extent BIAL has the right to disclose them, outside the Territory; (vii) Reporting on the status of ongoing commercial activities with respect to Licensed Products in the Field in and, to the extent BIAL has the right to disclose them, outside the Territory; (viii) Reviewing and agreeing the Agreed Sales Forecast; (ix) Resolving disputes in respect of proposed publications in accordance with Section 9.3; and (x) Performing such other responsibilities as may be assigned to the JSC pursuant to this Agreement or as may be mutually agreed upon in writing by the Parties from time to time.

Appears in 1 contract

Sources: License Agreement (Neurocrine Biosciences Inc)

JSC Responsibilities. Responsibilities of the The JSC shall be the followingresponsible for: (ia) Discussing coordinating the activities of the Parties under this Agreement and reviewing providing a forum to facilitate communications between the development and regulatory strategies and activities for the Licensed Products in and outside the Territory and, to the extent reasonably possible, coordinating strategies in and outside the TerritoryParties under this Agreement; (iib) Discussing reviewing and reviewing discussing the commercialization strategies Development, Manufacture and activities Commercialization of the Licensed Products in and outside the Territory and, to the extent reasonably possible, coordinating strategies in and outside the Territory; (iii) Discussing and reviewing the matters relating to supply that are not specifically addressed within the Supply Agreement of the Licensed Products by BIAL to NBIX for use hereunder; (iv) Discussing, reviewing and approving the Development and Regulatory Plan and amendments thereto prior to adoption or implementation thereof; (v) Discussing, reviewing and approving the Annual Commercialization Plan, and updates or amendments thereto prior to adoption or implementation thereof; (vi) Reporting on the status of ongoing Development Studies and other development activities with respect to Licensed Products in the Field in and, to the extent BIAL has the right to disclose them, outside the Territory; , including the activities of 3DMed and its Sublicensees to (viii) Reporting on Develop the status of ongoing commercial activities with respect to Licensed Products in the Field in andthe Territory in accordance with the Development Plan, (ii) Manufacture quantities of the Licensed Products for use in the Field in the Territory, (iii) following receipt of Regulatory Approval, launch, market, distribute and sell Licensed Products in the Field in the Territory, and (iv) subject to Section 2.2, 3DMed’s selection of Third Party service providers to support 3DMed’s efforts to Develop, Manufacture and Commercialize the Licensed Products in the Field in the Territory; (c) reviewing, discussing and approving changes to the Development Plan, overseeing the implementation of the Development Plan, and reviewing and discussing the Data and results of the Development activities under the Development Plan, in each case, subject to the provisions of Section 3.5, below; (d) reviewing and discussing, on an annual basis, commercial strategy, including branding, marketing, market access, and pricing for the Licensed Products in the Territory; (e) discussing at a high-level and exchanging relevant information relating to the Development, Manufacture and Commercialization activities for the Licensed Products undertaken by SELLAS and its Affiliates and sublicensees outside of the Territory (i) to the extent BIAL relevant to the Development, Manufacture and Commercialization of the Licensed Products in the Field in the Territory, and (ii) to the extent that SELLAS has the right to disclose them, outside the Territory; (viii) Reviewing and agreeing the Agreed Sales Forecast; (ix) Resolving disputes in respect of proposed publications in accordance with Section 9.3such information to 3DMed; and (xf) Performing performing such other responsibilities functions as may be assigned appropriate to further the JSC pursuant to purposes of this Agreement, as expressly set forth in this Agreement or as may be mutually agreed upon allocated to it by the Parties in writing by the Parties from time to timemutual agreement.

Appears in 1 contract

Sources: Exclusive License Agreement (SELLAS Life Sciences Group, Inc.)

JSC Responsibilities. Responsibilities of the JSC shall be the following: (i) Discussing and reviewing the development and regulatory strategies and activities for the Licensed Products in and outside the Territory and, to the extent reasonably possible, coordinating strategies in and outside the Territory;; *** Confidential Treatment Requested (ii) Discussing and reviewing the commercialization strategies and activities of the Licensed Products in and outside the Territory and, to the extent reasonably possible, coordinating strategies in and outside the Territory; (iii) Discussing and reviewing the matters relating to supply that are not specifically addressed within the Supply Agreement of the Licensed Products by BIAL to NBIX for use hereunder; (iv) Discussing, reviewing and approving the Development and Regulatory Plan and amendments thereto prior to adoption or implementation thereof; (v) Discussing, reviewing and approving the Annual Commercialization Plan, and updates or amendments thereto prior to adoption or implementation thereof; (vi) Reporting on the status of ongoing Development Studies and other development activities with respect to Licensed Products in the Field in and, to the extent BIAL has the right to disclose them, outside the Territory; (vii) Reporting on the status of ongoing commercial activities with respect to Licensed Products in the Field in and, to the extent BIAL has the right to disclose them, outside the Territory; (viii) Reviewing and agreeing the Agreed Sales Forecast; (ix) Resolving disputes in respect of proposed publications in accordance with Section 9.3; and (x) Performing such other responsibilities as may be assigned to the JSC pursuant to this Agreement or as may be mutually agreed upon in writing by the Parties from time to time.

Appears in 1 contract

Sources: License Agreement (Neurocrine Biosciences Inc)

JSC Responsibilities. Responsibilities of the The JSC shall be the followingresponsible for: (ia) Discussing coordinating the activities of the Parties under this Agreement and reviewing providing a forum to facilitate communications between the development and regulatory strategies and activities for the Licensed Products in and outside the Territory and, to the extent reasonably possible, coordinating strategies in and outside the TerritoryParties under this Agreement; (iib) Discussing reviewing and reviewing discussing the commercialization strategies Development, Manufacture and activities Commercialization of the Licensed Products in Compound and outside the Territory and, to the extent reasonably possible, coordinating strategies in and outside the Territory; (iii) Discussing and reviewing the matters relating to supply that are not specifically addressed within the Supply Agreement of the Licensed Products by BIAL to NBIX for use hereunder; (iv) Discussing, reviewing and approving the Development and Regulatory Plan and amendments thereto prior to adoption or implementation thereof; (v) Discussing, reviewing and approving the Annual Commercialization Plan, and updates or amendments thereto prior to adoption or implementation thereof; (vi) Reporting on the status of ongoing Development Studies and other development activities with respect to Licensed Products in the Field in and, to the extent BIAL has the right to disclose them, outside the Territory; , including the activities of Qilu and its Sublicensees to (viii) Reporting on Develop the status of ongoing commercial activities with respect to Licensed Compound and Licensed Products in the Field in andthe Territory in accordance with the Development Plan, (ii) Manufacture quantities of the Licensed Compound and Licensed Products for use in the Field in the Territory, (iii) following Regulatory Approval, launch, market, distribute and sell Licensed Products in the Field in the Territory, and (iv) subject to Section 2.2 and any consent required by Sesen for a sublicense of the License, Qilu’s selection of Third Party service providers to support Qilu’s efforts to Develop, Manufacture and Commercialize the Licensed Compound and Licensed Products in the Field in the Territory; (c) reviewing, discussing and approving changes to the Development Plan, overseeing the implementation of the Development Plan, and reviewing and discussing the Data and results of the Development activities under the Development Plan, in each case, subject to the provisions of Section 3.5, below; (d) discussing at a high-level and exchanging relevant information relating to the Development, Manufacture and Commercialization activities for the Licensed Compound and Licensed Products undertaken by Sesen and its Affiliates and sublicensees outside of the Field and outside of the Territory (i) to the extent BIAL relevant to the Development, Manufacture and Commercialization of the Licensed Compound and Licensed Products in the Field in the Territory, and (ii) to the extent that Sesen has the right to disclose them, outside the Territory; (viii) Reviewing and agreeing the Agreed Sales Forecast; (ix) Resolving disputes in respect of proposed publications in accordance with Section 9.3such information to Qilu; and (xe) Performing performing such other responsibilities functions as may be assigned appropriate to further the JSC pursuant to purposes of this Agreement, as expressly set forth in this Agreement or as may be mutually agreed upon allocated to it by the Parties in writing by the Parties from time to timemutual agreement.

Appears in 1 contract

Sources: Exclusive License Agreement (Sesen Bio, Inc.)